Dr. Ferrandon’s research focuses on how colorectal cancer forms in the body and what causes disparities in therapeutic responses. He has participated in studies that identified contextual molecular factors that influence how tumors respond to treatment, which has advanced understanding of cancer resistance signaling mechanisms. Dr. Ferrandon’s work has been featured in numerous peer-reviewed publications.
Education
- PhD: University of Lyon 1, Radiobiology, Molecular and Cellular Biology
- Postdoctoral fellow: Lerner Research Institute, Cleveland Clinic
Research Interests
- Colorectal cancer
- Biomarkers
- Radiation resistance
- Microbiome
- Familial adenomatous polyposis
Honors and Awards
- Excellence in Research Award, The American College of Surgeons, 2023
Editorial Activities
- Board member, Journal of Radiation Oncology and Research
- Board member, Radiation Research
- Reviewer, Cellular Oncology
- Reviewer, Frontiers in Endocrinology